Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00029030.xml
Journal of Pediatric Neurology 2020; 18(02): 118-122
DOI: 10.1055/s-0039-1683440
DOI: 10.1055/s-0039-1683440
Case Report
Central Nervous System Complications due to Human Herpesvirus 6 Infection in Pediatric Age Group
Further Information
Publication History
11 January 2019
08 February 2019
Publication Date:
13 March 2019 (online)
Abstract
Human herpesvirus 6 (HHV-6) has been demonstrated to be a neurotropic virus and has been linked to several neurological complications associated with a wide range of clinical outcomes. Here, we present data from immunocompetent children with a central neurological condition and intrathecal DNA detection of HHV-6 virus. Through these cases, physiopathology, investigations, and outcome of the disease will be described. Finally, specific treatment will be discussed.
-
References
- 1 Yamanishi K, Okuno T, Shiraki K. , et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1 (8,594): 1065-1067
- 2 Komaroff AL, Boeckh M, Eliason E, Phan T, Kaufer BB. Summary of the 10th international conference on Human Herpesviruses-6 and -7 (HHV-6A, -6B, and HHV-7). J Med Virol 2018; 90 (04) 625-630
- 3 Hall CB, Caserta MT, Schnabel KC. , et al. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 2004; 145 (04) 472-477
- 4 Tavakoli NP, Nattanmai S, Hull R. , et al. Detection and typing of human herpesvirus 6 by molecular methods in specimens from patients diagnosed with encephalitis or meningitis. J Clin Microbiol 2007; 45 (12) 3972-3978
- 5 Ward KN, Andrews NJ, Verity CM, Miller E, Ross EM. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child 2005; 90 (06) 619-623
- 6 Seeley WW, Marty FM, Holmes TM. , et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007; 69 (02) 156-165
- 7 De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005; 18 (01) 217-245
- 8 Yoshikawa T, Asano Y, Akimoto S. , et al. Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol 2002; 66 (04) 497-505
- 9 Friedman JE, Lyons MJ, Cu G. , et al. The association of the human herpesvirus-6 and MS. Mult Scler 1999; 5 (05) 355-362
- 10 Ward KN, Leong HN, Thiruchelvam AD, Atkinson CE, Clark DA. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 2007; 45 (04) 1298-1304
- 11 Kawamura Y, Sugata K, Ihira M. , et al. Different characteristics of human herpesvirus 6 encephalitis between primary infection and viral reactivation. J Clin Virol 2011; 51 (01) 12-19
- 12 Steiner I, Budka H, Chaudhuri A. , et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010; 17 (08) 999-e57
- 13 Ongrádi J, Ablashi DV, Yoshikawa T, Stercz B, Ogata M. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals. J Neurovirol 2017; 23 (01) 1-19
- 14 Olli-Lähdesmäki T, Haataja L, Parkkola R, Waris M, Bleyzac N, Ruuskanen O. High-dose ganciclovir in HHV-6 encephalitis of an immunocompetent child. Pediatr Neurol 2010; 43 (01) 53-56
- 15 Asano Y, Yoshikawa T, Kajita Y. , et al. Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 1992; 67 (12) 1484-1485